Ultra Advantage Liquid
NDC Package 69727-0002-1
Package Information
Ultra Advantage (abrotanum (artemisia abrotanum), anacardium orientale, fucus vesiculosus, helleborus niger, hypothalamus suis, lycopodium clavatum, thymolum, thymus serpyllum, thyroidinum (bovine), glandula suprarenalis suis, hepar suis, pancreas suis, cinchona officinalis, graphites, nicotinamidum, baryta carbonica, calcarea carbonica, calcarea phosphorica, magnesia phosphorica, solidago virgaurea) liquids is for temporary relief of symptoms related to excess appetite, stress, cravings, regulation of fat metabolism, emotional eating & detoxification. This formulation utilizes a liquid delivery system. Marketed by Elttac Inc Dba Swl, this product is identified by NDC 69727-0002.
Identification & Billing
Clinical Specifications
- ARTEMISIA ABROTANUM FLOWERING TOP 8 [hp_X]/mL
- BARIUM CARBONATE 12 [hp_X]/mL
- CINCHONA OFFICINALIS BARK 8 [hp_X]/mL
- FUCUS VESICULOSUS 8 [hp_X]/mL
- GRAPHITE 8 [hp_X]/mL
- HELLEBORUS NIGER ROOT 8 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 8 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 12 [hp_X]/mL
- NIACINAMIDE 8 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X]/mL
- PORK LIVER 8 [hp_X]/mL
- SEMECARPUS ANACARDIUM JUICE 8 [hp_X]/mL
- SOLIDAGO VIRGAUREA FLOWERING TOP 12 [hp_X]/mL
- SUS SCROFA ADRENAL GLAND 8 [hp_X]/mL
- SUS SCROFA HYPOTHALAMUS 8 [hp_X]/mL
- SUS SCROFA PANCREAS 8 [hp_X]/mL
- THYMOL 8 [hp_X]/mL
- THYMUS SERPYLLUM 8 [hp_X]/mL
- THYROID, BOVINE 8 [hp_X]/mL
- TRIBASIC CALCIUM PHOSPHATE 12 [hp_X]/mL
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 69727 - Elttac Inc Dba Swl
- 69727-0002 - Ultra Advantage
- 69727-0002-1 - 30 mL in 1 BOTTLE, SPRAY
- 69727-0002 - Ultra Advantage
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69727-0002-1 identifies a specific commercial package of 30 ml in 1 bottle, spray of Ultra Advantage, a human over the counter drug labeled by Elttac Inc Dba Swl. This liquid is formulated for oral use and contains artemisia abrotanum flowering top; barium carbonate; cinchona officinalis bark; fucus vesiculosus; graphite; helleborus niger root; lycopodium clavatum spore; magnesium phosphate, dibasic trihydrate; niacinamide; oyster shell calcium carbonate, crude; pork liver; semecarpus anacardium juice; solidago virgaurea flowering top; sus scrofa adrenal gland; sus scrofa hypothalamus; sus scrofa pancreas; thymol; thymus serpyllum; thyroid, bovine; tribasic calcium phosphate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Elttac Inc Dba Swl on December 12, 2018. The current certification is valid through December 31, 2026.
How is this Elttac Inc Dba Swl product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69727000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.